Announcements Trials
Browse Landscape

Phase

Phase NA 108Phase 2 94Phase 1/2 81Phase 1 81Phase 3 26Phase EARLY_PHASE1 17Phase 2/3 10Phase 4 3

Status

Completed 20Unknown 13Terminated 4Recruiting 3Withdrawn 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 33Neoplasms 17Prostatic Neoplasms 14Lung Neoplasms 12Carcinoma, Hepatocellular 11Carcinoma, Non-Small-Cell Lung 10Multiple Myeloma 9Colorectal Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Liver Neoplasms 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3Pancreatic Neoplasms 3

Interventions

Metronidazole 1Gemcitabine 1Enoxaparin 1Cefuroxime 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Pancreatic Neoplasms × Clear all
NCT05245877 2025-02-14

PREPOSTEROUS2

Helsinki University Central Hospital

Phase 4 Recruiting
800 enrolled
Gastrointestinal

Hemorrhage, Pancreatic Neoplasms, Thrombosis

NCT05784311 2024-10-21

SPARROW

Leiden University Medical Center

Phase 4 Recruiting
344 enrolled
Gastrointestinal

Pancreatic Neoplasms, Surgical Wound Infection

NCT05035147 2021-09-21

Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 4 Recruiting
934 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡